Oertli launches next generation microincision instruments

Article

Oertli has launched new instruments to be used in microincision surgery for the anterior and the posterior segments.

Oertli has launched new instruments to be used in microincision surgery for the anterior and the posterior segments.

For the anterior segment, Oertli has introduced the CO-MICS 2 tip for 1.6 mm phaco, which is fully compatible with the existing OS3, SwissTech and CataRhex platforms. This product builds on Oertli's portfolio of instruments that enable surgeons to perform coaxial microincision cataract surgery (CO-MICS), now, through a groundbreaking microincision of 1.6 mm.

In the posterior segment, the company has launched a new 23G autoseal PMS pars plana microincision surgery system set with self-sealing trocars, which is available as a complete vitrectomy pack for Oertli's OS3 NovitreX3000 platform or individually, as a sterile disposable set of 10 pieces.

The CO-MICS 2 set (left) combines phaco tip and irrigation sleeve to provide enhanced chamber stability during microcoaxial phaco. It provides the same performance and ultrasound times as standard phaco, with enhanced holdability force, stability and fluidic properties but reduced lateral forces, and no turbulence.

The 23G autoseal PMS pars plana microincision surgery system (below) for transconjunctival vitrectomy without the need for sutures has an integrated sealing valve, which does not necessitate sealing during surgery and enables easier and faster plug-sealing with no loss of pressure following vitrectomy.

Both the CO-MICS 2 and the 23G PMS are available now and can be seen by visiting Oertli at booth number 1560, Hall 15, during this year's ESCRS congress in September, Berlin, Germany.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.